Trispecific therapeutics against acute myeloid leukaemia

Details for Australian Patent Application No. 2010329925 (hide)

Owner Friedrich-Alexander-Universitat Erlangen-Nurnberg Fey , G.

Inventors Fey, Georg H.; Stein, Christoph; Kellner, Christian; Kugler, Markus

Agent Davies Collison Cave

Pub. Number AU-A-2010329925

PCT Pub. Number WO2011/070109

Priority 09015260.4 09.12.09 EP

Filing date 9 December 2010

Wipo publication date 16 June 2011

International Classifications

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

Event Publications

5 July 2012 PCT application entered the National Phase

  PCT publication WO2011/070109 Priority application(s): WO2011/070109

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010329928-Ejection device for ejecting small doses

2010329917-Methods of producing GH8 xylanase variants